Loading clinical trials...
Loading clinical trials...
Lactobacillus Plantarum PS128 May Improve Off Duration in Parkinson's Disease: a Pilot Study
The purpose of this study is to investigate the short term effects (12 Weeks) of Lactobacillus plantarum PS128 (PS128) on Parkinson's disease (PD) symptoms.
This study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 treatment for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.
Age
40 - 80 years
Sex
ALL
Healthy Volunteers
No
Professor Lu Neurological Clinic
Taoyuan, Guishan Dist., Taiwan
Start Date
June 4, 2019
Primary Completion Date
May 13, 2020
Completion Date
June 13, 2020
Last Updated
August 17, 2025
26
ACTUAL participants
daily ingestion of Lactobacillus plantarum PS128
DIETARY_SUPPLEMENT
Lead Sponsor
Professor Lu Neurological Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06113640